Research location

Ann Arbor

Michigan, United States

Published trials1,981

Site observations2,332

Linked trials published1,981

Page1 / 40

Research activity in Ann Arbor

Michigan, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 1,981 trials and 2,332 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Ann Arbor

1,981 linked trials · page 1 of 40

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After TreatmentNCT07293247 · 2026-10-14 · 1 site observation

Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic ScoreNCT07490067 · 2026-10-01 · 1 site observation

Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual TrialNCT07863180 · 2026-09-01 · 1 site observation

WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency DepartmentNCT07558265 · 2026-08-18 · 1 site observation

Leveraging Interventions for Needs and Knowledge in Diabetes (LINKD)NCT07676188 · 2026-08-03 · 1 site observation

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)NCT07492680 · 2026-07-27 · 1 site observation

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)NCT05996328 · 2026-07-24 · 1 site observation

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentNCT07444567 · 2026-07-24 · 1 site observation

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's MedicationsNCT07330258 · 2026-07-21 · 1 site observation

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)NCT07654361 · 2026-07-13 · 1 site observation

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's DiseaseNCT07005180 · 2026-06-30 · 1 site observation

The Bottle Optimization Testing Tiny Little Eaters StudyNCT07665983 · 2026-06-26 · 1 site observation

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS MutationsNCT07629960 · 2026-06-04 · 1 site observation

Prediction Augmented Screening InitiativeNCT06538636 · 2026-06-01 · 1 site observation

Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate CancerNCT06616155 · 2026-06-01 · 1 site observation

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionNCT07192952 · 2026-06-01 · 1 site observation

A Pilot Study of In-lab Dynamic Standing in Parkinson's DiseaseNCT07543861 · 2026-05-15 · 1 site observation

A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS TrialNCT07443943 · 2026-04-22 · 1 site observation

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize TrialNCT05379153 · 2026-04-21 · 1 site observation

Michigan Weight Navigation Program (MiWeigh) StudyNCT07465341 · 2026-04-09 · 1 site observation

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the LungNCT07499674 · 2026-03-31 · 1 site observation

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialNCT07200830 · 2026-03-31 · 1 site observation

A Long-Term Open-Label Study of ML-007C-MA in Adults With SchizophreniaNCT07459647 · 2026-03-31 · 1 site observation

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2NCT07288398 · 2026-03-03 · 1 site observation

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor FluctuationsNCT07432958 · 2026-02-25 · 1 site observation

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLCNCT06681220 · 2026-02-23 · 1 site observation

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung CancerNCT07428044 · 2026-02-13 · 1 site observation

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPDNCT07059091 · 2026-02-12 · 1 site observation

Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS TrialNCT07158021 · 2026-01-22 · 1 site observation

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney DiseaseNCT07271186 · 2026-01-09 · 1 site observation

A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer PatientsNCT07291414 · 2026-01-09 · 1 site observation

A Study of AZD0120 in Autoimmune DiseasesNCT07295847 · 2026-01-09 · 1 site observation

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP DeletionNCT07063745 · 2026-01-02 · 1 site observation

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILDNCT07333183 · 2025-12-23 · 1 site observation

Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) PatientsNCT07392879 · 2025-12-15 · 1 site observation

A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)NCT07221474 · 2025-12-12 · 1 site observation

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerNCT07007559 · 2025-12-10 · 1 site observation

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung CancerNCT05467748 · 2025-12-08 · 1 site observation

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic DysfunctionNCT07188805 · 2025-11-19 · 1 site observation

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyNCT07472517 · 2025-11-07 · 1 site observation

Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive ImpairmentsNCT07154511 · 2025-11-07 · 1 site observation

Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein SodiumNCT04008121 · 2025-11-06 · 1 site observation

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerNCT07085767 · 2025-11-03 · 1 site observation

The WiSE®-UP Study (The WiSE System Utilization & Performance Study)NCT07098858 · 2025-11-03 · 1 site observation

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic HerniaNCT05213676 · 2025-11-01 · 1 site observation

CCM OPEN HF RegistryNCT07112924 · 2025-11-01 · 1 site observation

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)NCT06906640 · 2025-10-28 · 1 site observation

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)NCT06906627 · 2025-10-28 · 1 site observation

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast MalignanciesNCT07211178 · 2025-10-27 · 1 site observation

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureNCT07069738 · 2025-10-22 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.